Cargando…
Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
Background: Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is increasingly being recognized as a cause of left ventricular (LV) hypertrophy (LVH) and progressive heart failure in elderly patients. However, little is known about the cardiac morphology of ATTR-CM and the association between the...
Autores principales: | Nakano, Tomoya, Onoue, Kenji, Terada, Chiyoko, Terasaki, Satoshi, Ishihara, Satomi, Hashimoto, Yukihiro, Nakada, Yasuki, Nakagawa, Hitoshi, Ueda, Tomoya, Seno, Ayako, Nishida, Taku, Watanabe, Makoto, Hoshii, Yoshinobu, Hatakeyama, Kinta, Sakaguchi, Yasuhiro, Ohbayashi, Chiho, Saito, Yoshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147607/ https://www.ncbi.nlm.nih.gov/pubmed/35629214 http://dx.doi.org/10.3390/jpm12050792 |
Ejemplares similares
-
Involvement of chronic inflammation via monocyte chemoattractant protein‐1 in uraemic cardiomyopathy: a human biopsy study
por: Nakano, Tomoya, et al.
Publicado: (2021) -
Histopathological and epigenetic changes in myocardium associated with cancer therapy‐related cardiac dysfunction
por: Terada, Chiyoko‐Ikeda, et al.
Publicado: (2022) -
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023) -
Diagnosis of Transthyretin Amyloid Cardiomyopathy
por: Hafeez, Adam S., et al.
Publicado: (2020) -
Hereditary transthyretin amyloid cardiomyopathy
por: Zheng, Yiliang, et al.
Publicado: (2023)